Showing results (191-200 of 9,661) with videos related to
Sort By:
Pageof 967
Leukemia|November 1, 1987
Immature megakaryocytes in the mouse: synergistic response to megakaryocyte potentiator, thrombopoietic stimulatory factor with interleukin 3S H Oon, N WilliamsLeukemia|January 2, 2022
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIAThierry Facon, Gordon Cook, Saad Z Usmani, et al.Leukemia|March 1, 2014
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activityK P Callahan, M Minhajuddin, C Corbett, et al.Leukemia|February 19, 2014
The leukemogenicity of Hoxa9 depends on alternative splicingC R Stadler, N Vegi, M A Mulaw, et al.Leukemia|June 18, 2011
The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in miceA J Deshpande, A Rouhi, Y Lin, et al.Leukemia|June 18, 2011
Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeatsM van der Burg, H Kreyenberg, A Willasch, et al.Leukemia|July 27, 2011
The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cellsK A Monaghan, T Khong, C J Burns, et al.Leukemia|July 27, 2011
Mobilization of stem and progenitor cells in cardiovascular diseasesW Wojakowski, U Landmesser, R Bachowski, et al.Leukemia|July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group studyS K Kumar, J H Lee, J J Lahuerta, et al.Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.Pageof 967